top of page

Evaluation

Projected timeline: Draft for either E2 or E1 due at the end of week 7, Term 3

Submission: Please submit each finished section of the evaluation for feedback as soon as they are ready to Josh's email

The general rule for writing for E1 is to evaluate three different research processes, each spanning a paragraph in length. (500 words maximum) 

The general rule for writing for E2 is to include three challenges/opportunities, each spanning a paragraph in length. (500 words maximum)

It is possible to achieve full marks by evaluating two research processes for E1 OR two challenges/opportunities for E2- however it is not recommended to do this for both. 

Evaluation template:

Powerpoints with unpacked examples for E1 & E2

Screen Shot 2020-07-31 at 8.38.27 am.png

Chief Assessors advice from 2019

Contains important do's and dont's for the Evaluation writing process.

Screen Shot 2020-09-18 at 8.27.19 am.png

Writing the Evaluation intro (150 words)

Please address the following four criteria;

  • Why did you choose your research project question?

  • What research processes did you use?

  • How was your research outcome presented?

  • Briefly describe your key findings.

Example;

"The objective of this research project was to investigate the claims of cognitive enhancement made by companies selling nootropics, specifically Modafinil, and to explore their efficacy from a scientific perspective. For this purpose, I accessed scientific journals and reports and conducted an expert interview in order to search for answers on the efficacy of nootropics and to investigate the market size of nootropic substances. My research outcome was presented in the format of an article to be featured on VICE, and targeted at senior students, university students and workers who might be interested in nootropics. The most surprising finding that I discovered is that although the efficacy of nootropics is contested within the scientific community, this doesn’t disprove the fact that they could work. I was also surprised at the pharmaceutical industry’s influence on the DEA (Drug Enforcement Agency), and their mishandling of information around other drugs, such as opioids."

Back
bottom of page